Aug 17, 2015 8:00 am EDT VolitionRx Announces Appointment of David Kratochvil as Chief Financial Officer
Aug 11, 2015 6:30 am EDT VolitionRx Announces Second Quarter 2015 Financial Results and Business Update
Aug 5, 2015 8:00 am EDT VolitionRx Schedules Second Quarter 2015 Earnings Conference Call and Business Update for Tuesday, August 11, 2015 at 8:30am ET
Jul 27, 2015 8:00 am EDT VolitionRx Engages Specialty Clinical Research Organization to Support Initial Entry of its NuQ(R) Colorectal Cancer Tests via U.S. CLIA Labs
Jun 23, 2015 8:00 am EDT VolitionRx Partners with Two Market Access Consulting Agencies to Support Market Access of NuQ(R) Colorectal Cancer Tests in Europe
